nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—Ibuprofen—Procarbazine—hematologic cancer	0.279	0.414	CrCrCtD
Esmolol—Atenolol—Procarbazine—hematologic cancer	0.249	0.369	CrCrCtD
Esmolol—Ibuprofen—Melphalan—hematologic cancer	0.147	0.217	CrCrCtD
Esmolol—Acebutolol—SLC22A1—hematologic cancer	0.000592	0.267	CrCbGaD
Esmolol—Ibuprofen—BCL2—hematologic cancer	0.000418	0.188	CrCbGaD
Esmolol—Ibuprofen—UGT1A1—hematologic cancer	0.000356	0.16	CrCbGaD
Esmolol—Atenolol—ABCB1—hematologic cancer	0.000186	0.084	CrCbGaD
Esmolol—Acebutolol—ABCB1—hematologic cancer	0.000172	0.0775	CrCbGaD
Esmolol—Metoprolol—ABCB1—hematologic cancer	0.000145	0.0654	CrCbGaD
Esmolol—Propafenone—ABCB1—hematologic cancer	0.000107	0.0482	CrCbGaD
Esmolol—Ibuprofen—ALB—hematologic cancer	8.72e-05	0.0393	CrCbGaD
Esmolol—Ibuprofen—ABCB1—hematologic cancer	8.32e-05	0.0375	CrCbGaD
Esmolol—Propranolol—ABCB1—hematologic cancer	7.33e-05	0.033	CrCbGaD
Esmolol—Oedema—Dexamethasone—hematologic cancer	5.14e-05	0.000173	CcSEcCtD
Esmolol—Vomiting—Carmustine—hematologic cancer	5.13e-05	0.000172	CcSEcCtD
Esmolol—Dizziness—Vincristine—hematologic cancer	5.1e-05	0.000171	CcSEcCtD
Esmolol—Vomiting—Alitretinoin—hematologic cancer	5.08e-05	0.000171	CcSEcCtD
Esmolol—Paraesthesia—Triamcinolone—hematologic cancer	5.08e-05	0.000171	CcSEcCtD
Esmolol—Drowsiness—Doxorubicin—hematologic cancer	5.08e-05	0.000171	CcSEcCtD
Esmolol—Feeling abnormal—Prednisolone—hematologic cancer	5.07e-05	0.00017	CcSEcCtD
Esmolol—Visual impairment—Methotrexate—hematologic cancer	5.07e-05	0.00017	CcSEcCtD
Esmolol—Headache—Carmustine—hematologic cancer	5.06e-05	0.00017	CcSEcCtD
Esmolol—Shock—Dexamethasone—hematologic cancer	5.05e-05	0.00017	CcSEcCtD
Esmolol—Shock—Betamethasone—hematologic cancer	5.05e-05	0.00017	CcSEcCtD
Esmolol—Dyspnoea—Triamcinolone—hematologic cancer	5.05e-05	0.00017	CcSEcCtD
Esmolol—Nervous system disorder—Betamethasone—hematologic cancer	5.04e-05	0.000169	CcSEcCtD
Esmolol—Nervous system disorder—Dexamethasone—hematologic cancer	5.04e-05	0.000169	CcSEcCtD
Esmolol—Agitation—Prednisone—hematologic cancer	5.04e-05	0.000169	CcSEcCtD
Esmolol—Vomiting—Ifosfamide—hematologic cancer	5.02e-05	0.000169	CcSEcCtD
Esmolol—Bradycardia—Epirubicin—hematologic cancer	5.01e-05	0.000168	CcSEcCtD
Esmolol—Headache—Alitretinoin—hematologic cancer	5.01e-05	0.000168	CcSEcCtD
Esmolol—Angioedema—Prednisone—hematologic cancer	5.01e-05	0.000168	CcSEcCtD
Esmolol—Nausea—Thalidomide—hematologic cancer	4.99e-05	0.000168	CcSEcCtD
Esmolol—Dyspepsia—Triamcinolone—hematologic cancer	4.98e-05	0.000167	CcSEcCtD
Esmolol—Neuropathy peripheral—Doxorubicin—hematologic cancer	4.98e-05	0.000167	CcSEcCtD
Esmolol—Hyperhidrosis—Betamethasone—hematologic cancer	4.97e-05	0.000167	CcSEcCtD
Esmolol—Hyperhidrosis—Dexamethasone—hematologic cancer	4.97e-05	0.000167	CcSEcCtD
Esmolol—Dizziness—Irinotecan—hematologic cancer	4.96e-05	0.000167	CcSEcCtD
Esmolol—Urticaria—Etoposide—hematologic cancer	4.96e-05	0.000167	CcSEcCtD
Esmolol—Rhinitis—Epirubicin—hematologic cancer	4.94e-05	0.000166	CcSEcCtD
Esmolol—Body temperature increased—Etoposide—hematologic cancer	4.93e-05	0.000166	CcSEcCtD
Esmolol—Syncope—Prednisone—hematologic cancer	4.92e-05	0.000165	CcSEcCtD
Esmolol—Vomiting—Vincristine—hematologic cancer	4.9e-05	0.000165	CcSEcCtD
Esmolol—Anorexia—Dexamethasone—hematologic cancer	4.9e-05	0.000165	CcSEcCtD
Esmolol—Anorexia—Betamethasone—hematologic cancer	4.9e-05	0.000165	CcSEcCtD
Esmolol—Urticaria—Prednisolone—hematologic cancer	4.89e-05	0.000164	CcSEcCtD
Esmolol—Asthenia—Cisplatin—hematologic cancer	4.89e-05	0.000164	CcSEcCtD
Esmolol—Pharyngitis—Epirubicin—hematologic cancer	4.89e-05	0.000164	CcSEcCtD
Esmolol—Cardiac disorder—Methotrexate—hematologic cancer	4.88e-05	0.000164	CcSEcCtD
Esmolol—Fatigue—Triamcinolone—hematologic cancer	4.88e-05	0.000164	CcSEcCtD
Esmolol—Urinary tract disorder—Epirubicin—hematologic cancer	4.86e-05	0.000163	CcSEcCtD
Esmolol—Pain—Triamcinolone—hematologic cancer	4.84e-05	0.000163	CcSEcCtD
Esmolol—Urethral disorder—Epirubicin—hematologic cancer	4.83e-05	0.000162	CcSEcCtD
Esmolol—Headache—Vincristine—hematologic cancer	4.83e-05	0.000162	CcSEcCtD
Esmolol—Loss of consciousness—Prednisone—hematologic cancer	4.82e-05	0.000162	CcSEcCtD
Esmolol—Hypotension—Dexamethasone—hematologic cancer	4.8e-05	0.000161	CcSEcCtD
Esmolol—Hypotension—Betamethasone—hematologic cancer	4.8e-05	0.000161	CcSEcCtD
Esmolol—Nausea—Carmustine—hematologic cancer	4.79e-05	0.000161	CcSEcCtD
Esmolol—Angiopathy—Methotrexate—hematologic cancer	4.77e-05	0.00016	CcSEcCtD
Esmolol—Vomiting—Mitoxantrone—hematologic cancer	4.77e-05	0.00016	CcSEcCtD
Esmolol—Vomiting—Irinotecan—hematologic cancer	4.77e-05	0.00016	CcSEcCtD
Esmolol—Nausea—Alitretinoin—hematologic cancer	4.75e-05	0.00016	CcSEcCtD
Esmolol—Convulsion—Prednisone—hematologic cancer	4.75e-05	0.00016	CcSEcCtD
Esmolol—Visual impairment—Epirubicin—hematologic cancer	4.75e-05	0.00016	CcSEcCtD
Esmolol—Chills—Methotrexate—hematologic cancer	4.72e-05	0.000159	CcSEcCtD
Esmolol—Headache—Irinotecan—hematologic cancer	4.7e-05	0.000158	CcSEcCtD
Esmolol—Headache—Mitoxantrone—hematologic cancer	4.7e-05	0.000158	CcSEcCtD
Esmolol—Nausea—Ifosfamide—hematologic cancer	4.69e-05	0.000158	CcSEcCtD
Esmolol—Feeling abnormal—Triamcinolone—hematologic cancer	4.67e-05	0.000157	CcSEcCtD
Esmolol—Anxiety—Prednisone—hematologic cancer	4.65e-05	0.000156	CcSEcCtD
Esmolol—Vomiting—Gemcitabine—hematologic cancer	4.65e-05	0.000156	CcSEcCtD
Esmolol—Bradycardia—Doxorubicin—hematologic cancer	4.64e-05	0.000156	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	4.63e-05	0.000156	CcSEcCtD
Esmolol—Paraesthesia—Dexamethasone—hematologic cancer	4.61e-05	0.000155	CcSEcCtD
Esmolol—Paraesthesia—Betamethasone—hematologic cancer	4.61e-05	0.000155	CcSEcCtD
Esmolol—Mental disorder—Methotrexate—hematologic cancer	4.61e-05	0.000155	CcSEcCtD
Esmolol—Erythema—Methotrexate—hematologic cancer	4.58e-05	0.000154	CcSEcCtD
Esmolol—Headache—Gemcitabine—hematologic cancer	4.58e-05	0.000154	CcSEcCtD
Esmolol—Nausea—Vincristine—hematologic cancer	4.58e-05	0.000154	CcSEcCtD
Esmolol—Flushing—Epirubicin—hematologic cancer	4.57e-05	0.000154	CcSEcCtD
Esmolol—Cardiac disorder—Epirubicin—hematologic cancer	4.57e-05	0.000154	CcSEcCtD
Esmolol—Rhinitis—Doxorubicin—hematologic cancer	4.57e-05	0.000154	CcSEcCtD
Esmolol—Pharyngitis—Doxorubicin—hematologic cancer	4.52e-05	0.000152	CcSEcCtD
Esmolol—Dyspepsia—Dexamethasone—hematologic cancer	4.52e-05	0.000152	CcSEcCtD
Esmolol—Dyspepsia—Betamethasone—hematologic cancer	4.52e-05	0.000152	CcSEcCtD
Esmolol—Urinary tract disorder—Doxorubicin—hematologic cancer	4.5e-05	0.000151	CcSEcCtD
Esmolol—Urticaria—Triamcinolone—hematologic cancer	4.5e-05	0.000151	CcSEcCtD
Esmolol—Dysgeusia—Methotrexate—hematologic cancer	4.49e-05	0.000151	CcSEcCtD
Esmolol—Asthenia—Etoposide—hematologic cancer	4.48e-05	0.000151	CcSEcCtD
Esmolol—Body temperature increased—Triamcinolone—hematologic cancer	4.48e-05	0.00015	CcSEcCtD
Esmolol—Oedema—Prednisone—hematologic cancer	4.47e-05	0.00015	CcSEcCtD
Esmolol—Angiopathy—Epirubicin—hematologic cancer	4.47e-05	0.00015	CcSEcCtD
Esmolol—Urethral disorder—Doxorubicin—hematologic cancer	4.47e-05	0.00015	CcSEcCtD
Esmolol—Decreased appetite—Betamethasone—hematologic cancer	4.47e-05	0.00015	CcSEcCtD
Esmolol—Decreased appetite—Dexamethasone—hematologic cancer	4.47e-05	0.00015	CcSEcCtD
Esmolol—Nausea—Mitoxantrone—hematologic cancer	4.46e-05	0.00015	CcSEcCtD
Esmolol—Nausea—Irinotecan—hematologic cancer	4.46e-05	0.00015	CcSEcCtD
Esmolol—Gastrointestinal disorder—Dexamethasone—hematologic cancer	4.43e-05	0.000149	CcSEcCtD
Esmolol—Gastrointestinal disorder—Betamethasone—hematologic cancer	4.43e-05	0.000149	CcSEcCtD
Esmolol—Fatigue—Betamethasone—hematologic cancer	4.43e-05	0.000149	CcSEcCtD
Esmolol—Fatigue—Dexamethasone—hematologic cancer	4.43e-05	0.000149	CcSEcCtD
Esmolol—Chills—Epirubicin—hematologic cancer	4.42e-05	0.000149	CcSEcCtD
Esmolol—Pruritus—Etoposide—hematologic cancer	4.42e-05	0.000148	CcSEcCtD
Esmolol—Shock—Prednisone—hematologic cancer	4.4e-05	0.000148	CcSEcCtD
Esmolol—Pain—Dexamethasone—hematologic cancer	4.39e-05	0.000148	CcSEcCtD
Esmolol—Pain—Betamethasone—hematologic cancer	4.39e-05	0.000148	CcSEcCtD
Esmolol—Visual impairment—Doxorubicin—hematologic cancer	4.39e-05	0.000148	CcSEcCtD
Esmolol—Nervous system disorder—Prednisone—hematologic cancer	4.39e-05	0.000147	CcSEcCtD
Esmolol—Skin disorder—Prednisone—hematologic cancer	4.35e-05	0.000146	CcSEcCtD
Esmolol—Nausea—Gemcitabine—hematologic cancer	4.34e-05	0.000146	CcSEcCtD
Esmolol—Vomiting—Cisplatin—hematologic cancer	4.33e-05	0.000146	CcSEcCtD
Esmolol—Hyperhidrosis—Prednisone—hematologic cancer	4.32e-05	0.000145	CcSEcCtD
Esmolol—Mental disorder—Epirubicin—hematologic cancer	4.31e-05	0.000145	CcSEcCtD
Esmolol—Erythema—Epirubicin—hematologic cancer	4.29e-05	0.000144	CcSEcCtD
Esmolol—Anorexia—Prednisone—hematologic cancer	4.26e-05	0.000143	CcSEcCtD
Esmolol—Feeling abnormal—Betamethasone—hematologic cancer	4.23e-05	0.000142	CcSEcCtD
Esmolol—Feeling abnormal—Dexamethasone—hematologic cancer	4.23e-05	0.000142	CcSEcCtD
Esmolol—Flushing—Doxorubicin—hematologic cancer	4.23e-05	0.000142	CcSEcCtD
Esmolol—Cardiac disorder—Doxorubicin—hematologic cancer	4.23e-05	0.000142	CcSEcCtD
Esmolol—Dysgeusia—Epirubicin—hematologic cancer	4.2e-05	0.000141	CcSEcCtD
Esmolol—Angiopathy—Doxorubicin—hematologic cancer	4.13e-05	0.000139	CcSEcCtD
Esmolol—Dizziness—Etoposide—hematologic cancer	4.13e-05	0.000139	CcSEcCtD
Esmolol—Chills—Doxorubicin—hematologic cancer	4.09e-05	0.000137	CcSEcCtD
Esmolol—Urticaria—Dexamethasone—hematologic cancer	4.08e-05	0.000137	CcSEcCtD
Esmolol—Urticaria—Betamethasone—hematologic cancer	4.08e-05	0.000137	CcSEcCtD
Esmolol—Dizziness—Prednisolone—hematologic cancer	4.07e-05	0.000137	CcSEcCtD
Esmolol—Asthenia—Triamcinolone—hematologic cancer	4.06e-05	0.000137	CcSEcCtD
Esmolol—Body temperature increased—Betamethasone—hematologic cancer	4.06e-05	0.000136	CcSEcCtD
Esmolol—Body temperature increased—Dexamethasone—hematologic cancer	4.06e-05	0.000136	CcSEcCtD
Esmolol—Nausea—Cisplatin—hematologic cancer	4.05e-05	0.000136	CcSEcCtD
Esmolol—Paraesthesia—Prednisone—hematologic cancer	4.02e-05	0.000135	CcSEcCtD
Esmolol—Pruritus—Triamcinolone—hematologic cancer	4.01e-05	0.000135	CcSEcCtD
Esmolol—Mental disorder—Doxorubicin—hematologic cancer	3.99e-05	0.000134	CcSEcCtD
Esmolol—Convulsion—Methotrexate—hematologic cancer	3.97e-05	0.000133	CcSEcCtD
Esmolol—Vomiting—Etoposide—hematologic cancer	3.97e-05	0.000133	CcSEcCtD
Esmolol—Erythema—Doxorubicin—hematologic cancer	3.97e-05	0.000133	CcSEcCtD
Esmolol—Agitation—Epirubicin—hematologic cancer	3.94e-05	0.000132	CcSEcCtD
Esmolol—Dyspepsia—Prednisone—hematologic cancer	3.94e-05	0.000132	CcSEcCtD
Esmolol—Headache—Etoposide—hematologic cancer	3.91e-05	0.000131	CcSEcCtD
Esmolol—Chest pain—Methotrexate—hematologic cancer	3.9e-05	0.000131	CcSEcCtD
Esmolol—Decreased appetite—Prednisone—hematologic cancer	3.89e-05	0.000131	CcSEcCtD
Esmolol—Dysgeusia—Doxorubicin—hematologic cancer	3.88e-05	0.000131	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.87e-05	0.00013	CcSEcCtD
Esmolol—Fatigue—Prednisone—hematologic cancer	3.86e-05	0.00013	CcSEcCtD
Esmolol—Headache—Prednisolone—hematologic cancer	3.86e-05	0.00013	CcSEcCtD
Esmolol—Syncope—Epirubicin—hematologic cancer	3.84e-05	0.000129	CcSEcCtD
Esmolol—Constipation—Prednisone—hematologic cancer	3.83e-05	0.000129	CcSEcCtD
Esmolol—Confusional state—Methotrexate—hematologic cancer	3.77e-05	0.000127	CcSEcCtD
Esmolol—Loss of consciousness—Epirubicin—hematologic cancer	3.77e-05	0.000127	CcSEcCtD
Esmolol—Dizziness—Triamcinolone—hematologic cancer	3.74e-05	0.000126	CcSEcCtD
Esmolol—Convulsion—Epirubicin—hematologic cancer	3.71e-05	0.000125	CcSEcCtD
Esmolol—Nausea—Etoposide—hematologic cancer	3.71e-05	0.000125	CcSEcCtD
Esmolol—Feeling abnormal—Prednisone—hematologic cancer	3.69e-05	0.000124	CcSEcCtD
Esmolol—Asthenia—Betamethasone—hematologic cancer	3.69e-05	0.000124	CcSEcCtD
Esmolol—Asthenia—Dexamethasone—hematologic cancer	3.69e-05	0.000124	CcSEcCtD
Esmolol—Nervous system disorder—Methotrexate—hematologic cancer	3.67e-05	0.000123	CcSEcCtD
Esmolol—Nausea—Prednisolone—hematologic cancer	3.66e-05	0.000123	CcSEcCtD
Esmolol—Chest pain—Epirubicin—hematologic cancer	3.65e-05	0.000123	CcSEcCtD
Esmolol—Agitation—Doxorubicin—hematologic cancer	3.65e-05	0.000123	CcSEcCtD
Esmolol—Anxiety—Epirubicin—hematologic cancer	3.64e-05	0.000122	CcSEcCtD
Esmolol—Pruritus—Betamethasone—hematologic cancer	3.63e-05	0.000122	CcSEcCtD
Esmolol—Pruritus—Dexamethasone—hematologic cancer	3.63e-05	0.000122	CcSEcCtD
Esmolol—Skin disorder—Methotrexate—hematologic cancer	3.63e-05	0.000122	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.62e-05	0.000122	CcSEcCtD
Esmolol—Hyperhidrosis—Methotrexate—hematologic cancer	3.61e-05	0.000121	CcSEcCtD
Esmolol—Vomiting—Triamcinolone—hematologic cancer	3.6e-05	0.000121	CcSEcCtD
Esmolol—Dry mouth—Epirubicin—hematologic cancer	3.57e-05	0.00012	CcSEcCtD
Esmolol—Anorexia—Methotrexate—hematologic cancer	3.56e-05	0.00012	CcSEcCtD
Esmolol—Syncope—Doxorubicin—hematologic cancer	3.56e-05	0.00012	CcSEcCtD
Esmolol—Urticaria—Prednisone—hematologic cancer	3.55e-05	0.000119	CcSEcCtD
Esmolol—Headache—Triamcinolone—hematologic cancer	3.55e-05	0.000119	CcSEcCtD
Esmolol—Body temperature increased—Prednisone—hematologic cancer	3.54e-05	0.000119	CcSEcCtD
Esmolol—Confusional state—Epirubicin—hematologic cancer	3.53e-05	0.000119	CcSEcCtD
Esmolol—Oedema—Epirubicin—hematologic cancer	3.5e-05	0.000118	CcSEcCtD
Esmolol—Hypotension—Methotrexate—hematologic cancer	3.49e-05	0.000117	CcSEcCtD
Esmolol—Loss of consciousness—Doxorubicin—hematologic cancer	3.49e-05	0.000117	CcSEcCtD
Esmolol—Shock—Epirubicin—hematologic cancer	3.44e-05	0.000116	CcSEcCtD
Esmolol—Convulsion—Doxorubicin—hematologic cancer	3.44e-05	0.000116	CcSEcCtD
Esmolol—Nervous system disorder—Epirubicin—hematologic cancer	3.43e-05	0.000115	CcSEcCtD
Esmolol—Skin disorder—Epirubicin—hematologic cancer	3.4e-05	0.000114	CcSEcCtD
Esmolol—Dizziness—Betamethasone—hematologic cancer	3.4e-05	0.000114	CcSEcCtD
Esmolol—Dizziness—Dexamethasone—hematologic cancer	3.4e-05	0.000114	CcSEcCtD
Esmolol—Hyperhidrosis—Epirubicin—hematologic cancer	3.38e-05	0.000114	CcSEcCtD
Esmolol—Chest pain—Doxorubicin—hematologic cancer	3.38e-05	0.000113	CcSEcCtD
Esmolol—Anxiety—Doxorubicin—hematologic cancer	3.37e-05	0.000113	CcSEcCtD
Esmolol—Nausea—Triamcinolone—hematologic cancer	3.36e-05	0.000113	CcSEcCtD
Esmolol—Paraesthesia—Methotrexate—hematologic cancer	3.36e-05	0.000113	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	3.35e-05	0.000113	CcSEcCtD
Esmolol—Anorexia—Epirubicin—hematologic cancer	3.34e-05	0.000112	CcSEcCtD
Esmolol—Dyspnoea—Methotrexate—hematologic cancer	3.33e-05	0.000112	CcSEcCtD
Esmolol—Somnolence—Methotrexate—hematologic cancer	3.32e-05	0.000112	CcSEcCtD
Esmolol—Dry mouth—Doxorubicin—hematologic cancer	3.3e-05	0.000111	CcSEcCtD
Esmolol—Dyspepsia—Methotrexate—hematologic cancer	3.29e-05	0.000111	CcSEcCtD
Esmolol—Hypotension—Epirubicin—hematologic cancer	3.27e-05	0.00011	CcSEcCtD
Esmolol—Vomiting—Betamethasone—hematologic cancer	3.27e-05	0.00011	CcSEcCtD
Esmolol—Vomiting—Dexamethasone—hematologic cancer	3.27e-05	0.00011	CcSEcCtD
Esmolol—Confusional state—Doxorubicin—hematologic cancer	3.26e-05	0.00011	CcSEcCtD
Esmolol—Decreased appetite—Methotrexate—hematologic cancer	3.25e-05	0.000109	CcSEcCtD
Esmolol—Oedema—Doxorubicin—hematologic cancer	3.24e-05	0.000109	CcSEcCtD
Esmolol—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.23e-05	0.000108	CcSEcCtD
Esmolol—Fatigue—Methotrexate—hematologic cancer	3.22e-05	0.000108	CcSEcCtD
Esmolol—Headache—Dexamethasone—hematologic cancer	3.22e-05	0.000108	CcSEcCtD
Esmolol—Headache—Betamethasone—hematologic cancer	3.22e-05	0.000108	CcSEcCtD
Esmolol—Asthenia—Prednisone—hematologic cancer	3.21e-05	0.000108	CcSEcCtD
Esmolol—Pain—Methotrexate—hematologic cancer	3.2e-05	0.000107	CcSEcCtD
Esmolol—Shock—Doxorubicin—hematologic cancer	3.19e-05	0.000107	CcSEcCtD
Esmolol—Nervous system disorder—Doxorubicin—hematologic cancer	3.17e-05	0.000107	CcSEcCtD
Esmolol—Pruritus—Prednisone—hematologic cancer	3.17e-05	0.000106	CcSEcCtD
Esmolol—Skin disorder—Doxorubicin—hematologic cancer	3.14e-05	0.000106	CcSEcCtD
Esmolol—Paraesthesia—Epirubicin—hematologic cancer	3.14e-05	0.000106	CcSEcCtD
Esmolol—Hyperhidrosis—Doxorubicin—hematologic cancer	3.13e-05	0.000105	CcSEcCtD
Esmolol—Dyspnoea—Epirubicin—hematologic cancer	3.12e-05	0.000105	CcSEcCtD
Esmolol—Somnolence—Epirubicin—hematologic cancer	3.11e-05	0.000105	CcSEcCtD
Esmolol—Anorexia—Doxorubicin—hematologic cancer	3.09e-05	0.000104	CcSEcCtD
Esmolol—Feeling abnormal—Methotrexate—hematologic cancer	3.08e-05	0.000104	CcSEcCtD
Esmolol—Dyspepsia—Epirubicin—hematologic cancer	3.08e-05	0.000104	CcSEcCtD
Esmolol—Nausea—Dexamethasone—hematologic cancer	3.05e-05	0.000103	CcSEcCtD
Esmolol—Nausea—Betamethasone—hematologic cancer	3.05e-05	0.000103	CcSEcCtD
Esmolol—Decreased appetite—Epirubicin—hematologic cancer	3.04e-05	0.000102	CcSEcCtD
Esmolol—Hypotension—Doxorubicin—hematologic cancer	3.03e-05	0.000102	CcSEcCtD
Esmolol—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.02e-05	0.000102	CcSEcCtD
Esmolol—Fatigue—Epirubicin—hematologic cancer	3.02e-05	0.000101	CcSEcCtD
Esmolol—Constipation—Epirubicin—hematologic cancer	2.99e-05	0.000101	CcSEcCtD
Esmolol—Pain—Epirubicin—hematologic cancer	2.99e-05	0.000101	CcSEcCtD
Esmolol—Urticaria—Methotrexate—hematologic cancer	2.97e-05	9.98e-05	CcSEcCtD
Esmolol—Dizziness—Prednisone—hematologic cancer	2.96e-05	9.94e-05	CcSEcCtD
Esmolol—Body temperature increased—Methotrexate—hematologic cancer	2.96e-05	9.93e-05	CcSEcCtD
Esmolol—Paraesthesia—Doxorubicin—hematologic cancer	2.91e-05	9.77e-05	CcSEcCtD
Esmolol—Dyspnoea—Doxorubicin—hematologic cancer	2.89e-05	9.7e-05	CcSEcCtD
Esmolol—Feeling abnormal—Epirubicin—hematologic cancer	2.88e-05	9.69e-05	CcSEcCtD
Esmolol—Somnolence—Doxorubicin—hematologic cancer	2.88e-05	9.67e-05	CcSEcCtD
Esmolol—Dyspepsia—Doxorubicin—hematologic cancer	2.85e-05	9.58e-05	CcSEcCtD
Esmolol—Vomiting—Prednisone—hematologic cancer	2.84e-05	9.56e-05	CcSEcCtD
Esmolol—Decreased appetite—Doxorubicin—hematologic cancer	2.81e-05	9.46e-05	CcSEcCtD
Esmolol—Headache—Prednisone—hematologic cancer	2.8e-05	9.42e-05	CcSEcCtD
Esmolol—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.79e-05	9.39e-05	CcSEcCtD
Esmolol—Fatigue—Doxorubicin—hematologic cancer	2.79e-05	9.38e-05	CcSEcCtD
Esmolol—Urticaria—Epirubicin—hematologic cancer	2.78e-05	9.34e-05	CcSEcCtD
Esmolol—Pain—Doxorubicin—hematologic cancer	2.77e-05	9.3e-05	CcSEcCtD
Esmolol—Constipation—Doxorubicin—hematologic cancer	2.77e-05	9.3e-05	CcSEcCtD
Esmolol—Body temperature increased—Epirubicin—hematologic cancer	2.77e-05	9.3e-05	CcSEcCtD
Esmolol—Asthenia—Methotrexate—hematologic cancer	2.68e-05	9.02e-05	CcSEcCtD
Esmolol—Feeling abnormal—Doxorubicin—hematologic cancer	2.67e-05	8.97e-05	CcSEcCtD
Esmolol—Nausea—Prednisone—hematologic cancer	2.66e-05	8.93e-05	CcSEcCtD
Esmolol—Pruritus—Methotrexate—hematologic cancer	2.65e-05	8.89e-05	CcSEcCtD
Esmolol—Urticaria—Doxorubicin—hematologic cancer	2.57e-05	8.64e-05	CcSEcCtD
Esmolol—Body temperature increased—Doxorubicin—hematologic cancer	2.56e-05	8.6e-05	CcSEcCtD
Esmolol—Asthenia—Epirubicin—hematologic cancer	2.51e-05	8.44e-05	CcSEcCtD
Esmolol—Pruritus—Epirubicin—hematologic cancer	2.48e-05	8.32e-05	CcSEcCtD
Esmolol—Dizziness—Methotrexate—hematologic cancer	2.47e-05	8.31e-05	CcSEcCtD
Esmolol—Vomiting—Methotrexate—hematologic cancer	2.38e-05	7.99e-05	CcSEcCtD
Esmolol—Headache—Methotrexate—hematologic cancer	2.34e-05	7.87e-05	CcSEcCtD
Esmolol—Asthenia—Doxorubicin—hematologic cancer	2.32e-05	7.81e-05	CcSEcCtD
Esmolol—Dizziness—Epirubicin—hematologic cancer	2.31e-05	7.78e-05	CcSEcCtD
Esmolol—Pruritus—Doxorubicin—hematologic cancer	2.29e-05	7.7e-05	CcSEcCtD
Esmolol—Vomiting—Epirubicin—hematologic cancer	2.22e-05	7.48e-05	CcSEcCtD
Esmolol—Nausea—Methotrexate—hematologic cancer	2.22e-05	7.46e-05	CcSEcCtD
Esmolol—Headache—Epirubicin—hematologic cancer	2.19e-05	7.37e-05	CcSEcCtD
Esmolol—Dizziness—Doxorubicin—hematologic cancer	2.14e-05	7.19e-05	CcSEcCtD
Esmolol—Nausea—Epirubicin—hematologic cancer	2.08e-05	6.98e-05	CcSEcCtD
Esmolol—Vomiting—Doxorubicin—hematologic cancer	2.06e-05	6.92e-05	CcSEcCtD
Esmolol—Headache—Doxorubicin—hematologic cancer	2.03e-05	6.82e-05	CcSEcCtD
Esmolol—Nausea—Doxorubicin—hematologic cancer	1.92e-05	6.46e-05	CcSEcCtD
Esmolol—ADRB1—Signaling Pathways—STAT5B—hematologic cancer	1.54e-05	0.00062	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—JAK1—hematologic cancer	1.53e-05	0.000617	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PRKCG—hematologic cancer	1.53e-05	0.000617	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RAC2—hematologic cancer	1.53e-05	0.000616	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—DKK1—hematologic cancer	1.52e-05	0.000611	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—STAT5B—hematologic cancer	1.51e-05	0.000606	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ADCY7—hematologic cancer	1.49e-05	0.000602	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CSF2—hematologic cancer	1.47e-05	0.000594	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—IL2RA—hematologic cancer	1.46e-05	0.000589	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ADCY7—hematologic cancer	1.46e-05	0.000589	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—XIAP—hematologic cancer	1.45e-05	0.000585	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CSF2—hematologic cancer	1.44e-05	0.000581	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—IL2RA—hematologic cancer	1.43e-05	0.000577	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—JAK1—hematologic cancer	1.42e-05	0.000573	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PRKCG—hematologic cancer	1.42e-05	0.000573	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—XIAP—hematologic cancer	1.42e-05	0.000573	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SH2B3—hematologic cancer	1.42e-05	0.000571	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SMARCA4—hematologic cancer	1.42e-05	0.000571	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GZMB—hematologic cancer	1.41e-05	0.000567	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PRKCG—hematologic cancer	1.39e-05	0.000561	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—JAK1—hematologic cancer	1.39e-05	0.000561	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SH2B3—hematologic cancer	1.39e-05	0.000558	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SMARCA4—hematologic cancer	1.39e-05	0.000558	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GZMB—hematologic cancer	1.38e-05	0.000555	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CTNNA1—hematologic cancer	1.37e-05	0.000554	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—EIF4EBP1—hematologic cancer	1.37e-05	0.00055	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HSPB1—hematologic cancer	1.37e-05	0.00055	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCL3—hematologic cancer	1.37e-05	0.00055	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SDC1—hematologic cancer	1.35e-05	0.000544	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PTHLH—hematologic cancer	1.35e-05	0.000544	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CTNNA1—hematologic cancer	1.34e-05	0.000542	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HSPB1—hematologic cancer	1.34e-05	0.000538	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCL3—hematologic cancer	1.34e-05	0.000538	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—EIF4EBP1—hematologic cancer	1.34e-05	0.000538	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—IL2RA—hematologic cancer	1.33e-05	0.000535	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PTHLH—hematologic cancer	1.32e-05	0.000532	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SDC1—hematologic cancer	1.32e-05	0.000532	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PTGER4—hematologic cancer	1.32e-05	0.00053	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—LCK—hematologic cancer	1.31e-05	0.000527	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—IL2RA—hematologic cancer	1.3e-05	0.000524	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PTGER4—hematologic cancer	1.29e-05	0.000518	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—H3F3A—hematologic cancer	1.28e-05	0.000517	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—LCK—hematologic cancer	1.28e-05	0.000516	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—H3F3A—hematologic cancer	1.25e-05	0.000505	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PRKCZ—hematologic cancer	1.25e-05	0.000502	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PRKCZ—hematologic cancer	1.22e-05	0.000491	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CG—hematologic cancer	1.22e-05	0.000491	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PARP1—hematologic cancer	1.2e-05	0.000485	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CG—hematologic cancer	1.19e-05	0.00048	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FBXW7—hematologic cancer	1.18e-05	0.000477	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PARP1—hematologic cancer	1.18e-05	0.000475	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HDAC2—hematologic cancer	1.16e-05	0.000468	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CXCR4—hematologic cancer	1.16e-05	0.000468	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FBXW7—hematologic cancer	1.16e-05	0.000467	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HDAC2—hematologic cancer	1.14e-05	0.000458	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CXCR4—hematologic cancer	1.14e-05	0.000458	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CBL—hematologic cancer	1.13e-05	0.000456	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IL3—hematologic cancer	1.12e-05	0.000451	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CBL—hematologic cancer	1.11e-05	0.000446	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CG—hematologic cancer	1.11e-05	0.000446	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PTPN1—hematologic cancer	1.1e-05	0.000444	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IL3—hematologic cancer	1.1e-05	0.000441	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PTPN11—hematologic cancer	1.09e-05	0.000438	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RASGRP1—hematologic cancer	1.08e-05	0.000437	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CG—hematologic cancer	1.08e-05	0.000436	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HSP90AA1—hematologic cancer	1.08e-05	0.000435	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SYK—hematologic cancer	1.08e-05	0.000435	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PTPN1—hematologic cancer	1.08e-05	0.000434	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CD—hematologic cancer	1.07e-05	0.000432	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PTPN11—hematologic cancer	1.06e-05	0.000428	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RASGRP1—hematologic cancer	1.06e-05	0.000427	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SYK—hematologic cancer	1.06e-05	0.000426	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HSP90AA1—hematologic cancer	1.06e-05	0.000426	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CREB1—hematologic cancer	1.05e-05	0.000424	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CD—hematologic cancer	1.05e-05	0.000422	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—STAT1—hematologic cancer	1.04e-05	0.00042	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CCL2—hematologic cancer	1.03e-05	0.000415	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CREB1—hematologic cancer	1.03e-05	0.000415	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—IL6R—hematologic cancer	1.03e-05	0.000414	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—STAT1—hematologic cancer	1.02e-05	0.00041	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3R1—hematologic cancer	1.01e-05	0.000408	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CCL2—hematologic cancer	1.01e-05	0.000406	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—IL6R—hematologic cancer	1.01e-05	0.000405	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3R1—hematologic cancer	9.9e-06	0.000399	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—JAK2—hematologic cancer	9.84e-06	0.000396	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—MAP2K1—hematologic cancer	9.8e-06	0.000395	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—GRB2—hematologic cancer	9.75e-06	0.000393	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CD—hematologic cancer	9.73e-06	0.000392	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PDGFA—hematologic cancer	9.72e-06	0.000392	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—JAK2—hematologic cancer	9.62e-06	0.000387	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—KITLG—hematologic cancer	9.58e-06	0.000386	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—MAP2K1—hematologic cancer	9.58e-06	0.000386	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—GRB2—hematologic cancer	9.53e-06	0.000384	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CD—hematologic cancer	9.52e-06	0.000383	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PDGFA—hematologic cancer	9.51e-06	0.000383	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—KITLG—hematologic cancer	9.37e-06	0.000378	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—STAT5A—hematologic cancer	9.37e-06	0.000377	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CB—hematologic cancer	9.34e-06	0.000376	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CDKN2B—hematologic cancer	9.29e-06	0.000374	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3R1—hematologic cancer	9.19e-06	0.00037	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—STAT5A—hematologic cancer	9.16e-06	0.000369	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CB—hematologic cancer	9.14e-06	0.000368	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CDKN2B—hematologic cancer	9.08e-06	0.000366	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3R1—hematologic cancer	8.99e-06	0.000362	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CD86—hematologic cancer	8.98e-06	0.000362	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—JAK2—hematologic cancer	8.93e-06	0.00036	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HES1—hematologic cancer	8.86e-06	0.000357	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NCOR1—hematologic cancer	8.81e-06	0.000355	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CD86—hematologic cancer	8.78e-06	0.000354	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—JAK2—hematologic cancer	8.74e-06	0.000352	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CSF2—hematologic cancer	8.71e-06	0.000351	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FGF1—hematologic cancer	8.71e-06	0.000351	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HES1—hematologic cancer	8.66e-06	0.000349	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NCOR1—hematologic cancer	8.62e-06	0.000347	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FOXO1—hematologic cancer	8.58e-06	0.000346	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—IL2—hematologic cancer	8.58e-06	0.000346	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PDGFRB—hematologic cancer	8.57e-06	0.000345	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FGF1—hematologic cancer	8.52e-06	0.000343	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CSF2—hematologic cancer	8.52e-06	0.000343	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CB—hematologic cancer	8.48e-06	0.000342	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PDGFRA—hematologic cancer	8.43e-06	0.00034	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—JAK1—hematologic cancer	8.41e-06	0.000339	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PRKCG—hematologic cancer	8.41e-06	0.000339	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FOXO1—hematologic cancer	8.4e-06	0.000338	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—IL2—hematologic cancer	8.39e-06	0.000338	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PDGFRB—hematologic cancer	8.38e-06	0.000338	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CB—hematologic cancer	8.3e-06	0.000334	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PDGFRA—hematologic cancer	8.25e-06	0.000332	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PRKCG—hematologic cancer	8.22e-06	0.000331	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—JAK1—hematologic cancer	8.22e-06	0.000331	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IL2RA—hematologic cancer	7.85e-06	0.000316	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—IL2—hematologic cancer	7.79e-06	0.000314	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TERT—hematologic cancer	7.76e-06	0.000313	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IL2RA—hematologic cancer	7.68e-06	0.000309	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—IL2—hematologic cancer	7.62e-06	0.000307	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TERT—hematologic cancer	7.59e-06	0.000306	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PDGFB—hematologic cancer	7.58e-06	0.000305	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PDGFB—hematologic cancer	7.41e-06	0.000298	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TSC2—hematologic cancer	7.4e-06	0.000298	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TSC2—hematologic cancer	7.24e-06	0.000292	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FGFR3—hematologic cancer	7.12e-06	0.000287	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MAPK14—hematologic cancer	7.05e-06	0.000284	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FGFR3—hematologic cancer	6.97e-06	0.000281	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ESR1—hematologic cancer	6.92e-06	0.000279	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MAPK14—hematologic cancer	6.9e-06	0.000278	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FN1—hematologic cancer	6.83e-06	0.000275	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ESR1—hematologic cancer	6.77e-06	0.000273	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—BAD—hematologic cancer	6.75e-06	0.000272	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NFKBIA—hematologic cancer	6.75e-06	0.000272	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NOTCH1—hematologic cancer	6.69e-06	0.000269	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FN1—hematologic cancer	6.68e-06	0.000269	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NFKBIA—hematologic cancer	6.61e-06	0.000266	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—BAD—hematologic cancer	6.61e-06	0.000266	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CD80—hematologic cancer	6.55e-06	0.000264	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NOTCH1—hematologic cancer	6.54e-06	0.000263	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CG—hematologic cancer	6.54e-06	0.000263	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—KIT—hematologic cancer	6.54e-06	0.000263	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—NRAS—hematologic cancer	6.54e-06	0.000263	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PTPN11—hematologic cancer	6.42e-06	0.000259	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CD80—hematologic cancer	6.41e-06	0.000258	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CG—hematologic cancer	6.4e-06	0.000258	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—KIT—hematologic cancer	6.4e-06	0.000258	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—NRAS—hematologic cancer	6.4e-06	0.000258	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PTPN11—hematologic cancer	6.28e-06	0.000253	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—MAPK3—hematologic cancer	6.26e-06	0.000252	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CREB1—hematologic cancer	6.22e-06	0.000251	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—BRAF—hematologic cancer	6.15e-06	0.000248	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—MAPK3—hematologic cancer	6.13e-06	0.000247	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCL2—hematologic cancer	6.09e-06	0.000245	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CREB1—hematologic cancer	6.09e-06	0.000245	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IL6R—hematologic cancer	6.07e-06	0.000245	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CREBBP—hematologic cancer	6.06e-06	0.000244	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—BRAF—hematologic cancer	6.01e-06	0.000242	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCL2—hematologic cancer	5.96e-06	0.00024	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IL6R—hematologic cancer	5.94e-06	0.000239	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CREBBP—hematologic cancer	5.93e-06	0.000239	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MAP2K1—hematologic cancer	5.79e-06	0.000233	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CD—hematologic cancer	5.75e-06	0.000232	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—PIK3CA—hematologic cancer	5.69e-06	0.000229	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MAP2K1—hematologic cancer	5.66e-06	0.000228	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—KRAS—hematologic cancer	5.63e-06	0.000227	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CD—hematologic cancer	5.62e-06	0.000226	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—PIK3CA—hematologic cancer	5.57e-06	0.000224	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—KRAS—hematologic cancer	5.51e-06	0.000222	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—FGF2—hematologic cancer	5.5e-06	0.000222	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3R1—hematologic cancer	5.43e-06	0.000219	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—FGF2—hematologic cancer	5.38e-06	0.000217	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3R1—hematologic cancer	5.31e-06	0.000214	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—JAK2—hematologic cancer	5.28e-06	0.000212	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—PIK3CA—hematologic cancer	5.17e-06	0.000208	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—JAK2—hematologic cancer	5.16e-06	0.000208	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MDM2—hematologic cancer	5.15e-06	0.000207	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—PIK3CA—hematologic cancer	5.06e-06	0.000204	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MDM2—hematologic cancer	5.04e-06	0.000203	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CB—hematologic cancer	5.01e-06	0.000202	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MTOR—hematologic cancer	5.01e-06	0.000202	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MTOR—hematologic cancer	4.9e-06	0.000197	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CB—hematologic cancer	4.9e-06	0.000197	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—HRAS—hematologic cancer	4.78e-06	0.000193	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CDKN1B—hematologic cancer	4.7e-06	0.000189	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—HRAS—hematologic cancer	4.68e-06	0.000188	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AKT1—hematologic cancer	4.65e-06	0.000187	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CASP3—hematologic cancer	4.61e-06	0.000186	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IL2—hematologic cancer	4.6e-06	0.000185	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CDKN1B—hematologic cancer	4.6e-06	0.000185	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—IL6—hematologic cancer	4.58e-06	0.000184	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AKT1—hematologic cancer	4.55e-06	0.000183	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CASP3—hematologic cancer	4.51e-06	0.000182	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IL2—hematologic cancer	4.5e-06	0.000181	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CCND1—hematologic cancer	4.49e-06	0.000181	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—IL6—hematologic cancer	4.48e-06	0.00018	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—JUN—hematologic cancer	4.48e-06	0.00018	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CCND1—hematologic cancer	4.39e-06	0.000177	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—JUN—hematologic cancer	4.38e-06	0.000176	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CDKN1A—hematologic cancer	4.34e-06	0.000175	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PTEN—hematologic cancer	4.33e-06	0.000174	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CDKN1A—hematologic cancer	4.25e-06	0.000171	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MAPK8—hematologic cancer	4.24e-06	0.000171	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PTEN—hematologic cancer	4.24e-06	0.000171	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AKT1—hematologic cancer	4.22e-06	0.00017	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MAPK8—hematologic cancer	4.14e-06	0.000167	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AKT1—hematologic cancer	4.13e-06	0.000166	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—EP300—hematologic cancer	4.13e-06	0.000166	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—EP300—hematologic cancer	4.04e-06	0.000163	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—SRC—hematologic cancer	4.02e-06	0.000162	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—SRC—hematologic cancer	3.93e-06	0.000158	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—VEGFA—hematologic cancer	3.91e-06	0.000158	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—STAT3—hematologic cancer	3.87e-06	0.000156	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—NRAS—hematologic cancer	3.86e-06	0.000156	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—VEGFA—hematologic cancer	3.83e-06	0.000154	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—STAT3—hematologic cancer	3.79e-06	0.000153	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—NRAS—hematologic cancer	3.78e-06	0.000152	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MAPK3—hematologic cancer	3.7e-06	0.000149	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MAPK3—hematologic cancer	3.62e-06	0.000146	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—MYC—hematologic cancer	3.6e-06	0.000145	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TGFB1—hematologic cancer	3.59e-06	0.000145	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—MYC—hematologic cancer	3.52e-06	0.000142	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TGFB1—hematologic cancer	3.51e-06	0.000141	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—KRAS—hematologic cancer	3.32e-06	0.000134	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—KRAS—hematologic cancer	3.25e-06	0.000131	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PIK3CA—hematologic cancer	3.05e-06	0.000123	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PIK3CA—hematologic cancer	2.99e-06	0.00012	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—TP53—hematologic cancer	2.96e-06	0.000119	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—TP53—hematologic cancer	2.89e-06	0.000116	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—HRAS—hematologic cancer	2.83e-06	0.000114	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—HRAS—hematologic cancer	2.76e-06	0.000111	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—IL6—hematologic cancer	2.7e-06	0.000109	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—IL6—hematologic cancer	2.65e-06	0.000107	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AKT1—hematologic cancer	2.5e-06	0.000101	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AKT1—hematologic cancer	2.44e-06	9.83e-05	CbGpPWpGaD
